Vietnam Analgesics Market Report: Trends, Growth and Forecast (2026-2032)
By Product (Systemic Analgesics (Adult Analgesics, Paediatric Analgesics, Combined Systemic Analgesics), Topical Analgesics/Anaesthetic), By Drug Type (Opioid Analgesics (Strong Opioids, Weak Opioids), Non-opioid Analgesics (Acetaminophen, Aspirin, Combination Products, Diclofenac, Dipyrone, Ibuprofen, Ketoprofen, Naproxen, OTC Triptans), Compound/Combination Analgesics (Opioid + Non-Opioid Combinations, Multi-Ingredient Non-Opioid Combinations)), By Route of Administration (Oral, Parenteral/Injectable, Topical/External, Transdermal, Rectal/Other), By Pain Type (Acute Pain, Chronic Pain, Breakthrough Pain), By Application (Surgical & Post-operative Pain, Musculoskeletal Pain, Neuropathic Pain, Cancer Pain, Migraine/Headache, Dental Pain, Others), By Sales Channel (Retail Offline (Offline Pharmacies, Hospital Pharmacies), Retail Online (Online Pharmacies)), By Prescription Type (Prescription, OTC), By Formulation (Tablets, Capsules, Liquids, Injectables, Gels/Creams, Patches), By End User (Hospitals, Clinics/ASCs, Homecare) ... Read more
|
Major Players
|
Vietnam Analgesics Market Statistics and Insights, 2026
- Market Size Statistics
- Analgesics market size in Vietnam was valued at USD 395 million in 2025 and is estimated at USD 410 million in 2026.
- The market size is expected to grow to USD 470 million by 2032.
- Market to register a CAGR of around 2.51% during 2026-32.
- Product Shares
- Systemic analgesics grabbed market share of 85%.
- Competition
- More than 15 companies are actively engaged in producing analgesics in Vietnam.
- Top 5 companies acquired around 45% of the market share.
- United International Pharma Co Ltd, Borden Co (Pte) Ltd, National Day Pharmaceutical JSC, GlaxoSmithKline Consumer Healthcare Vietnam Co Ltd, DHG Pharmaceutical JSC etc., are few of the top companies.
- Sales Channel
- Retail offline grabbed 80% of the market.
Vietnam Analgesics Market Outlook
Vietnam analgesics market size was valued at USD 395 million in 2025 and is projected to grow from USD 410 million in 2026 to USD 470 million by 2032, exhibiting a CAGR of 2.51% during the forecast period. Growth remains steady as self medication becomes more common and consumers increasingly use pain relief products for headaches, stress related discomfort, age related pain, and other mild conditions in daily life.
Demand remains supported by the country’s ageing population, which keeps the need for routine pain management visible across regular self care. Joint pain, back pain, muscle discomfort, and other persistent situations can be found in a majority of older adults. Pain relief through practical means like analgesics has a significant everyday relevance, and companies continue to provide many products with new and better formulations for the convenience of the elderly.
By product, systemic analgesics hold the leading share at around 85%, supported by their familiar use for headaches, fever, muscle pain, and other common symptoms that consumers want to manage quickly and simply. At the same time, price sensitivity remains an important factor, as buyers compare lower cost options more closely and local generic products continue to offer a more affordable choice. Alongside this, analgesics are also gaining wider visibility through stronger digital access, making it easier for consumers to discover and compare products.
By sales channel, retail offline leads with around 80% share, as consumers still prefer physical pharmacies for quick access, immediate purchase, and trusted advice. Store based buying remains especially important when analgesics are needed without delay. Even though digital commerce is expanding, offline pharmacies continue to hold the stronger position because of convenience, pharmacist guidance, and a regulated medicine environment. In addition, rising inbound tourism creates more room for travel related pain relief purchases across the category.

Vietnam Analgesics Market Growth DriverAgeing Keeps Everyday Pain Relief Relevant
A growing older population supports analgesics demand in Vietnam. Older adults are more likely to face joint pain, back pain, muscle discomfort, and other recurring conditions that need regular symptom relief. This keeps everyday pain management important in self care and supports steady demand for familiar analgesic products that offer quick and practical use in daily life.
Economic and Social Commission for Asia and the Pacific (ESCAP)’s 2025 demographic profile for Vietnam shows that the population aged 60 and above reaches 14.7 million, equal to 14.5% of the total population. The same source shows that the 65+ population reaches 9.6 million, or 9.5% of the population, while life expectancy at birth stands at 74.9 years. This age structure keeps pain management needs visible across the country.
Vietnam Analgesics Market ChallengePrice Pressure Favors Lower-Cost Choices
Price sensitivity remains a key challenge for analgesics in Vietnam. Pain relief products are bought frequently, so consumers notice price changes quickly and compare lower cost options more closely. This creates pressure on branded players, especially when local generic products remain more affordable and household budgets stay careful in routine healthcare spending.
The National Statistics Office of Vietnam reports that the consumer price index rises by 3.31% in 2025 compared with 2024, while gross retail sales of consumer goods and services reach VND 7,008.9 trillion, up 9.2% year on year in current prices. In this setting, value for money remains important in daily medicine purchases, which makes it harder for higher priced analgesics to widen demand.
Unlock Market Intelligence
Explore the market potential with our data-driven report
Vietnam Analgesics Market TrendDigital Reach Starts Shaping Product Discovery
A clearer trend in Vietnam is the stronger role of digital access in how consumers discover and compare analgesics. Buyers increasingly use online channels, mobile connectivity, and digital information tools to check products, look at formats, and engage with brand communication. This supports wider visibility for pain relief products and helps consumers make faster self care decisions.
Official data shows this digital base is expanding. The Ministry of Industry and Trade says retail online exceeded USD 25 billion in 2025. At the same time, the Ministry of Science and Technology says 5G already covers 26% of the population, with about 11,000 5G base stations deployed, while 4G covers 99.8% of the population. This stronger digital environment is making analgesics easier to promote and discover.
Vietnam Analgesics Market OpportunityTourism Creates New Use Cases
Inbound tourism creates a clear opportunity for analgesics in Vietnam, especially for products used for headaches, travel fatigue, muscle aches, and minor body discomfort during trips. Strong tourist movement also supports demand for convenient pain relief formats that are easy to carry and easy to buy during travel, especially in high traffic destinations.
The Ministry of Culture, Sports and Tourism reports that Vietnam receives 21.5 million international arrivals in 2025, up 21% year on year, while domestic tourist numbers reach 135 million, up 22.7% from 2024. Total tourism revenue is estimated at around VND 1 quadrillion in 2025. This sustained visitor flow creates a wider platform for travel related analgesics purchases.
Unlock Market Intelligence
Explore the market potential with our data-driven report
Vietnam Analgesics Market Segmentation Analysis
By Product
- Systemic Analgesics
- Adult Analgesics
- Paediatric Analgesics
- Combined Systemic Analgesics
- Topical Analgesics/Anaesthetic
The segment with the highest share under the product is systemic analgesics, holding around 85% of the Vietnam analgesics market in value terms. This segment remains ahead because oral pain relief products are still the most familiar choice for headaches, fever, muscle pain, and other common symptoms that consumers want to manage quickly and simply in daily life.
Its leading position is supported by the country’s ageing profile. ESCAP’s 2025 demographic data for Vietnam shows that the population aged 60 and above reaches 14.7 million, while the 65+ population reaches 9.6 million. Since older adults are more likely to experience recurring aches and pains, systemic analgesics continue to see broad and regular use in routine self care.

By Sales Channel
- Retail Offline
- Offline Pharmacies
- Hospital Pharmacies
- Retail Online
- Online Pharmacies
The segment with the highest share under the sales channel is retail offline, accounting for around 80% of the Vietnam analgesics market in value terms. This channel leads because consumers still prefer physical pharmacies for quick access, immediate purchase, and trusted advice when choosing pain relief products. Store based buying remains important, especially when analgesics are needed without delay.
Retail offline also benefits from a regulated medicine environment. The Ministry of Health’s circular 12/2025/TT-BYT, issued on 16 May 2025, guides the amended Law on Pharmacy and includes principles for classifying over the counter medicines. At the same time, the Ministry of Industry and Trade says retail online exceeded USD 25 billion in 2025. Even with digital growth, this regulated structure helps keep physical pharmacy access central to analgesics purchases.
List of Companies Covered in Vietnam Analgesics Market
The companies listed below are highly influential in the Vietnam analgesics market, with a significant market share and a strong impact on industry developments.
- United International Pharma Co Ltd
- Borden Co (Pte) Ltd
- National Day Pharmaceutical JSC
- GlaxoSmithKline Consumer Healthcare Vietnam Co Ltd
- DHG Pharmaceutical JSC
- UPSA Laboratoires
- Imexpharm Pharmaceutical JSC
- Hisamitsu Pharmaceutical Vietnam Co Ltd
- ICA Biotechnological Pharmaceutical JSC
- Bao Linh Oriental Medicine Co Ltd
Competitive Landscape
In 2025, analgesics in Vietnam recorded stable retail value growth, driven by the increasing popularity of self-medication, rising stress levels, and an ageing population seeking relief from mild pain and chronic conditions. GlaxoSmithKline Consumer Healthcare Vietnam Co Ltd led the market with a 15.1% value share, followed by DHG Pharmaceutical JSC at 10.9%, with strong competition between international and local players. Demand was particularly strong for acetaminophen and topical analgesics, supported by rising participation in physical activities and increasing awareness of paediatric pain management. While e-commerce expanded overall, pharmacies remained the dominant distribution channel due to accessibility, trust, and the need for immediate relief. Growth was further supported by product innovation, expanding generic offerings, and increasing consumer preference for convenient and affordable treatment options.
Frequently Asked Questions
Related Report
- Market Segmentation
- Research Scope
- Research Methodology
- Definitions and Assumptions
- Executive Summary
- Vietnam Analgesics Market Policies, Regulations, and Standards
- Vietnam Analgesics Market Dynamics
- Growth Factors
- Challenges
- Trends
- Opportunities
- Vietnam Analgesics Market Statistics, 2022-2032F
- Market Size & Growth Outlook
- By Revenues in USD Million
- Market Segmentation & Growth Outlook
- By Product
- Systemic Analgesics- Market Insights and Forecast 2022-2032, USD Million
- Adult Analgesics- Market Insights and Forecast 2022-2032, USD Million
- Paediatric Analgesics- Market Insights and Forecast 2022-2032, USD Million
- Combined Systemic Analgesics- Market Insights and Forecast 2022-2032, USD Million
- Topical Analgesics/Anaesthetic- Market Insights and Forecast 2022-2032, USD Million
- Systemic Analgesics- Market Insights and Forecast 2022-2032, USD Million
- By Drug Type
- Opioid Analgesics- Market Insights and Forecast 2022-2032, USD Million
- Strong Opioids- Market Insights and Forecast 2022-2032, USD Million
- Weak Opioids- Market Insights and Forecast 2022-2032, USD Million
- Non-opioid Analgesics- Market Insights and Forecast 2022-2032, USD Million
- Acetaminophen- Market Insights and Forecast 2022-2032, USD Million
- Aspirin- Market Insights and Forecast 2022-2032, USD Million
- Combination Products- Market Insights and Forecast 2022-2032, USD Million
- Diclofenac- Market Insights and Forecast 2022-2032, USD Million
- Dipyrone- Market Insights and Forecast 2022-2032, USD Million
- Ibuprofen- Market Insights and Forecast 2022-2032, USD Million
- Ketoprofen- Market Insights and Forecast 2022-2032, USD Million
- Naproxen- Market Insights and Forecast 2022-2032, USD Million
- OTC Triptans- Market Insights and Forecast 2022-2032, USD Million
- Compound/Combination Analgesics- Market Insights and Forecast 2022-2032, USD Million
- Opioid + Non-Opioid Combinations- Market Insights and Forecast 2022-2032, USD Million
- Multi-Ingredient Non-Opioid Combinations- Market Insights and Forecast 2022-2032, USD Million
- Opioid Analgesics- Market Insights and Forecast 2022-2032, USD Million
- By Route of Administration
- Oral- Market Insights and Forecast 2022-2032, USD Million
- Parenteral/Injectable- Market Insights and Forecast 2022-2032, USD Million
- Topical/External- Market Insights and Forecast 2022-2032, USD Million
- Transdermal- Market Insights and Forecast 2022-2032, USD Million
- Rectal/Other- Market Insights and Forecast 2022-2032, USD Million
- By Pain Type
- Acute Pain- Market Insights and Forecast 2022-2032, USD Million
- Chronic Pain- Market Insights and Forecast 2022-2032, USD Million
- Breakthrough Pain- Market Insights and Forecast 2022-2032, USD Million
- By Application
- Surgical & Post-operative Pain- Market Insights and Forecast 2022-2032, USD Million
- Musculoskeletal Pain- Market Insights and Forecast 2022-2032, USD Million
- Neuropathic Pain- Market Insights and Forecast 2022-2032, USD Million
- Cancer Pain- Market Insights and Forecast 2022-2032, USD Million
- Migraine/Headache- Market Insights and Forecast 2022-2032, USD Million
- Dental Pain- Market Insights and Forecast 2022-2032, USD Million
- Others- Market Insights and Forecast 2022-2032, USD Million
- By Sales Channel
- Retail Offline- Market Insights and Forecast 2022-2032, USD Million
- Offline Pharmacies- Market Insights and Forecast 2022-2032, USD Million
- Hospital Pharmacies- Market Insights and Forecast 2022-2032, USD Million
- Retail Online- Market Insights and Forecast 2022-2032, USD Million
- Online Pharmacies- Market Insights and Forecast 2022-2032, USD Million
- Retail Offline- Market Insights and Forecast 2022-2032, USD Million
- By Prescription Type
- Prescription- Market Insights and Forecast 2022-2032, USD Million
- OTC- Market Insights and Forecast 2022-2032, USD Million
- By Formulation
- Tablets- Market Insights and Forecast 2022-2032, USD Million
- Capsules- Market Insights and Forecast 2022-2032, USD Million
- Liquids- Market Insights and Forecast 2022-2032, USD Million
- Injectables- Market Insights and Forecast 2022-2032, USD Million
- Gels/Creams- Market Insights and Forecast 2022-2032, USD Million
- Patches- Market Insights and Forecast 2022-2032, USD Million
- By End User
- Hospitals- Market Insights and Forecast 2022-2032, USD Million
- Clinics/ASCs- Market Insights and Forecast 2022-2032, USD Million
- Homecare- Market Insights and Forecast 2022-2032, USD Million
- By Competitors
- Competition Characteristics
- Market Share & Analysis
- By Product
- Market Size & Growth Outlook
- Vietnam Systemic Analgesics Market Statistics, 2022-2032
- Market Size & Growth Outlook
- By Revenues in USD Million
- Market Segmentation & Growth Outlook
- By Drug Type- Market Insights and Forecast 2022-2032, USD Million
- By Route of Administration- Market Insights and Forecast 2022-2032, USD Million
- By Pain Type- Market Insights and Forecast 2022-2032, USD Million
- By Application- Market Insights and Forecast 2022-2032, USD Million
- By Sales Channel- Market Insights and Forecast 2022-2032, USD Million
- By Prescription Type- Market Insights and Forecast 2022-2032, USD Million
- By Formulation- Market Insights and Forecast 2022-2032, USD Million
- By End User- Market Insights and Forecast 2022-2032, USD Million
- Market Size & Growth Outlook
- Vietnam Topical Analgesics/Anaesthetic Market Statistics, 2022-2032
- Market Size & Growth Outlook
- By Revenues in USD Million
- Market Segmentation & Growth Outlook
- By Drug Type- Market Insights and Forecast 2022-2032, USD Million
- By Route of Administration- Market Insights and Forecast 2022-2032, USD Million
- By Pain Type- Market Insights and Forecast 2022-2032, USD Million
- By Application- Market Insights and Forecast 2022-2032, USD Million
- By Sales Channel- Market Insights and Forecast 2022-2032, USD Million
- By Prescription Type- Market Insights and Forecast 2022-2032, USD Million
- By Formulation- Market Insights and Forecast 2022-2032, USD Million
- By End User- Market Insights and Forecast 2022-2032, USD Million
- Market Size & Growth Outlook
- Competitive Outlook
- Company Profiles
- GlaxoSmithKline Consumer Healthcare Vietnam Co Ltd
- Business Description
- Product Portfolio
- Collaborations & Alliances
- Recent Developments
- Financial Details
- Others
- DHG Pharmaceutical JSC
- Business Description
- Product Portfolio
- Collaborations & Alliances
- Recent Developments
- Financial Details
- Others
- UPSA Laboratoires
- Business Description
- Product Portfolio
- Collaborations & Alliances
- Recent Developments
- Financial Details
- Others
- Imexpharm Pharmaceutical JSC
- Business Description
- Product Portfolio
- Collaborations & Alliances
- Recent Developments
- Financial Details
- Others
- Hisamitsu Pharmaceutical Vietnam Co Ltd
- Business Description
- Product Portfolio
- Collaborations & Alliances
- Recent Developments
- Financial Details
- Others
- United International Pharma Co Ltd
- Business Description
- Product Portfolio
- Collaborations & Alliances
- Recent Developments
- Financial Details
- Others
- Borden Co (Pte) Ltd
- Business Description
- Product Portfolio
- Collaborations & Alliances
- Recent Developments
- Financial Details
- Others
- National Day Pharmaceutical JSC
- Business Description
- Product Portfolio
- Collaborations & Alliances
- Recent Developments
- Financial Details
- Others
- ICA Biotechnological Pharmaceutical JSC
- Business Description
- Product Portfolio
- Collaborations & Alliances
- Recent Developments
- Financial Details
- Others
- Bao Linh Oriental Medicine Co Ltd
- Business Description
- Product Portfolio
- Collaborations & Alliances
- Recent Developments
- Financial Details
- Others
- GlaxoSmithKline Consumer Healthcare Vietnam Co Ltd
- Company Profiles
- Disclaimer
| Segment | Sub-Segment |
|---|---|
| By Product |
|
| By Drug Type |
|
| By Route of Administration |
|
| By Pain Type |
|
| By Application |
|
| By Sales Channel |
|
| By Prescription Type |
|
| By Formulation |
|
| By End User |
|
Research Methodology
This study followed a structured approach comprising four key phases to assess the size and scope of the electro-oxidation market. The process began with thorough secondary research to collect data on the target market, related markets, and broader industry context. These findings, along with preliminary assumptions and estimates, were then validated through extensive primary research involving industry experts from across the value chain. To calculate the overall market size, both top-down and bottom-up methodologies were employed. Finally, market segmentation and data triangulation techniques were applied to refine and validate segment-level estimations.
Secondary Research
The secondary research phase involved gathering data from a wide range of credible and published sources. This step helped in identifying industry trends, defining market segmentation, and understanding the market landscape and value chain.
Sources consulted during this phase included:
- Company annual reports, investor presentations, and press releases
- Industry white papers and certified publications
- Trade directories and market-recognized databases
- Articles from authoritative authors and reputable journals
- Gold and silver standard websites
Secondary research was critical in mapping out the industry's value chain and monetary flow, identifying key market segments, understanding regional variations, and tracking significant industry developments.
Other key sources:
- Financial disclosures
- Industry associations and trade bodies
- News outlets and business magazines
- Academic journals and research studies
- Paid industry databases
Primary Research
To validate secondary data and gain deeper market insights, primary research was conducted with key stakeholders across both the supply and demand sides of the market.
On the demand side, participants included decision-makers and influencers from end-user industries—such as CIOs, CTOs, and CSOs—who provided first-hand perspectives on market needs, product usage, and future expectations.
On the supply side, interviews were conducted with manufacturers, industry associations, and institutional participants to gather insights into current offerings, product pipelines, and market challenges.
Primary interviews provided critical inputs such as:
- Market size and revenue data
- Product and service breakdowns
- Market forecasts
- Regional and application-specific trends
Stakeholders consulted included:
- Leading OEM and solution providers
- Channel and distribution partners
- End users across various applications
- Independent consultants and industry specialists
Market Size Estimation and Data Triangulation
- Identifying Key Market Participants (Secondary Research)
- Goal: To identify the major players or companies in the target market. This typically involves using publicly available data sources such as industry reports, market research publications, and financial statements of companies.
- Tools: Reports from firms like Gartner, Forrester, Euromonitor, Statista, IBISWorld, and others. Public financial statements, news articles, and press releases from top market players.
- Extracting Earnings of Key Market Participants
- Goal: To estimate the earnings generated from the product or service being analyzed. This step helps in understanding the revenue potential of each market player in a specific geography.
- Methods: Earnings data can be gathered from:
- Publicly available financial reports (for listed companies).
- Interviews and primary data sources from professionals, such as Directors, VPs, SVPs, etc. This is especially useful for understanding more nuanced, internal data that isn't publicly disclosed.
- Annual reports and investor presentations of key players.
- Data Collation and Development of a Relevant Data Model
- Goal: To collate inputs from both primary and secondary sources into a structured, data-driven model for market estimation. This model will incorporate key market KPIs and any independent variables relevant to the market.
- Key KPIs: These could include:
- Market size, growth rate, and demand drivers.
- Industry-specific metrics like market share, average revenue per customer (ARPC), or average deal size.
- External variables, such as economic growth rates, inflation rates, or commodity prices, that could affect the market.
- Data Modeling: Based on this data, the market forecasts are developed for the next 5 years. A combination of trend analysis, scenario modeling, and statistical regression might be used to generate projections.
- Scenario Analysis
- Goal: To test different assumptions and validate how sensitive the market is to changes in key variables (e.g., market demand, regulatory changes, technological disruptions).
- Types of Scenarios:
- Base Case: Based on current assumptions and historical data.
- Best-Case Scenario: Assuming favorable market conditions, regulatory environments, and technological advancements.
- Worst-Case Scenario: Accounting for adverse factors, such as economic downturns, stricter regulations, or unexpected disruptions.











